Dyno Nobel (DNL) H2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 earnings summary
8 Jun, 2026Executive summary
Achieved strong FY2025 performance with EBIT ex IMIs up 23% to $714m, NPAT ex IMIs up 6% to $423m, and transformation benefits totaling $134m, progressing to a pure-play explosives business with major asset sales and $579m upfront cash proceeds.
Safety performance improved, with a 19% reduction in TRIFR and a 40% decrease in injury severity, and no serious harm incidents.
Strategic focus on technology, capital discipline, and growth in EMEA and LATAM, with new leadership and the Nitradyn JV expanding into defence energetics.
Fertilisers business separation nearly complete, with a clear exit path for Phosphate Hill by September 2026.
Financial highlights
Group statutory revenue was $5,345m (flat YoY), with EBITDA ex IMIs up 10% to $1,012m and EBIT ex IMIs up 23% to $714m.
Explosives underlying revenue grew 2% to $2,970m, with underlying EBIT up 16% to $434m.
Statutory after-tax loss of $53m, including $477m in IMIs from asset sales and impairments.
ROIC including goodwill improved to 8.2% (from 6.3%); excluding goodwill, ROIC at 11.5%.
Net debt/EBITDA at 1.4x, with $930m returned to shareholders under the $1.4bn capital return program.
Outlook and guidance
FY2026 explosives EBIT forecasted at $460m–$500m, with transformation benefits exit run rate targeted at 65–75% of the $300m ambition.
Earnings expected to be second-half weighted; debottlenecking at Moranbah to offset lost capacity from Gibson Island.
Phosphate Hill FY26 production forecast: 790kmt–850kmt; costs per tonne: $720–$780.
New GHG reduction targets: 25% by 2030, 50% by 2036, net zero by 2050.
Latest events from Dyno Nobel
- Record underlying EBIT growth and transformation progress, despite statutory net loss from impairments.DNL
H2 20248 Jun 2026 - Transformation and asset sales drive return to profit and strong 2H outlook.DNL
H1 20258 Jun 2026 - EBIT up 39% and NPAT ex IMIs up 83% YoY; FY26 EBIT guidance and buyback progress reaffirmed.DNL
H1 20268 Jun 2026 - Strong financial results, strategic transformation, and robust shareholder support defined the AGM.DNL
AGM 20253 Feb 2026 - Doubling EBIT in 3–4 years, tech-driven growth, and strong capital returns targeted.DNL
Investor Showcase 20243 Feb 2026 - Fertilizer sale talks end; AUD 900m buyback begins, with FY24 outlook steady.DNL
Investor Update3 Feb 2026